​

Mirum Pharmaceuticals (MIRM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Mirum Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$186.37M

Latest Revenue (Q)

$77.88M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Mirum Pharmaceuticals Revenue by Period

Mirum Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$186.37M141.85%
2022-12-31$77.06M302.66%
2021-12-31$19.14M100.00%
2020-12-31-100.00%
2019-12-31--

Mirum Pharmaceuticals generated $186.37M in revenue during NA 2023, up 141.85% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$77.88M12.50%
2024-03-31$69.22M-0.48%
2023-12-31$69.55M45.74%
2023-09-30$47.73M27.28%
2023-06-30$37.50M18.67%
2023-03-31$31.60M13.23%
2022-12-31$27.91M48.59%
2022-09-30$18.78M7.41%
2022-06-30$17.48M35.62%
2022-03-31$12.89M310.83%
2021-12-31$3.14M-37.24%
2021-09-30$5.00M-54.55%
2021-06-30$11.00M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Mirum Pharmaceuticals generated $77.88M in revenue during Q2 2024, up 12.50% compared to the previous quarter, and up 246.46% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue Breakdown

Mirum Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Product$178.87M$75.06M$3.14M
License Revenue$7.50M--
License-$2.00M$16.00M

Mirum Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (95.98%), and License Revenue (4.02%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Product$90.30M$68.92M$69.55M$47.73M$32.50M$29.10M$27.91M$18.78M$17.48M$10.89M
License and Other Revenue$75.00K$305.00K--------
License Revenue---$7.50M------
License----$5.00M$2.50M---$2.00M

Mirum Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.92%), and License and Other Revenue (0.08%).

Mirum Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23
Rest of World$32.17M
UNITED STATES$146.70M

Mirum Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (82.01%), and Rest of World (17.99%).

Quarterly Revenue by Country

CountrySep 24Mar 24
UNITED STATES$73.91M$56.11M
Rest Of World$16.40M$12.81M

Mirum Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (81.84%), and Rest Of World (18.16%).

Mirum Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
APLSApellis Pharmaceuticals$366.28M$176.57M
IMCRImmunocore$249.43M$75.40M
BPMCBlueprint Medicines$249.38M$128.18M
MIRMMirum Pharmaceuticals$186.37M$77.88M
ARQTArcutis Biotherapeutics$59.61M$30.86M
LYRALyra Therapeutics$1.56M$195.00K
XFORX4 Pharmaceuticals-$560.00K
KALVKalVista Pharmaceuticals--
MLTXMoonLake Immunotherapeutics--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
LRMRLarimar Therapeutics--

MIRM Revenue FAQ

What is Mirum Pharmaceuticals’s yearly revenue?

Mirum Pharmaceuticals's yearly revenue for 2023 was $186.37M, representing an increase of 141.85% compared to 2022. The company's yearly revenue for 2022 was $77.06M, representing an increase of 302.66% compared to 2021. MIRM's yearly revenue for 2021 was $19.14M, representing an increase of 100.00% compared to 2020.

What is Mirum Pharmaceuticals’s quarterly revenue?

Mirum Pharmaceuticals's quarterly revenue for Q2 2024 was $77.88M, a 12.50% increase from the previous quarter (Q1 2024), and a 107.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $69.22M, a -0.48% decrease from the previous quarter (Q4 2023), and a 119.07% increase year-over-year (Q1 2023). MIRM's quarterly revenue for Q4 2023 was $69.55M, a 45.74% increase from the previous quarter (Q3 2023), and a 149.24% increase year-over-year (Q4 2022).

What is Mirum Pharmaceuticals’s revenue growth rate?

Mirum Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 873.84%, and for the last 5 years (2019-2023) was 0%.

What are Mirum Pharmaceuticals’s revenue streams?

Mirum Pharmaceuticals's revenue streams in c 23 are Product, and License Revenue. Product generated $178.87M in revenue, accounting 95.98% of the company's total revenue, up 138.30% year-over-year. License Revenue generated $7.5M in revenue, accounting 4.02% of the company's total revenue

What is Mirum Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Mirum Pharmaceuticals was Product. This segment made a revenue of $178.87M, representing 95.98% of the company's total revenue.